Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Inhibikase Therapeutics, Inc. | 108,176 | reported | 30 Jun 2025 | tx 5+1,818,341 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Jun 2025 | GRANT_AWARD | Inhibikase Therapeutics, Inc. | 108,176 | 0.00 USD | deriv |
| 14 Feb 2025 | GRANT_AWARD | Inhibikase Therapeutics, Inc. | 116,585 | 0.00 USD | deriv |
| 14 Feb 2025 | GRANT_AWARD | Inhibikase Therapeutics, Inc. | 73,580 | 0.00 USD | deriv |
| 21 Oct 2024 | PURCHASE | Inhibikase Therapeutics, Inc. | 1,460,000 | 1.37 USD | |
| 21 Oct 2024 | GRANT_AWARD | Inhibikase Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |